Phoenix Biotech Acquisition Corp.
PBAX | NASDAQ
$5.85
+$0.37 (+6.75%)
At close: Feb 14, 2024, 03:56 PM ET
Market Data
Market Cap $36.47M
Enterprise Value $44.16M
Beta 0.04
Average Volume N/A
Shares Outstanding (Diluted) 42.18M
Shares Change YoY 8541.08%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -46.8%
1Y CAGR (ann.) -44.3%
5Y CAGR (ann.) N/A
All-Time CAGR -21.3%
Valuation
PE Ratio -0.27
Forward PE N/A
PEG Ratio -0.01
Forward PEG -0.01
PS Ratio N/A
Forward PS N/A
PB Ratio -1.20
P/FCF Ratio -3.01
P/Adj. FCF Ratio -2.50
P/OCF Ratio -20.17
EV/Sales N/A
EV/EBIT N/A
EV/EBITDA -14.62
EV/FCF -3.65
Earnings Yield -366.7%
FCF Yield -33.2%
Adj. FCF Yield -40.0%
Financial Health
Net Debt $7.69M
Total Debt $8.63M
Cash & Short-Term Investments $937.51K
Total Assets $1.9M
Current Ratio 0.05
Quick Ratio 0.05
Debt / Equity Ratio -0.28
Debt / EBITDA -2.86
Debt / FCF -0.71
OCF / Debt -1.40
Interest Coverage 20.34
Altman Z-Score -90.84
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -20.5%
Returns
Return on Assets -5015.7%
Return on Equity 766.1%
Return on Invested Capital 79.9%
Return on Capital Employed 57.3%
Return on Tangible Assets -5015.7%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -38.4%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -50.1%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Sep 29, 2023
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-12.1M
Free Cash Flow $-12.1M
Adj. Free Cash Flow $-14.58M
FCF Per Share -$0.29
OCF Per Share -$0.29
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-17.48M
EBITDA $-3.02M
Net Income $-95.3M
EPS (Diluted) -$21.45
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove PBAX